サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494500

アジア太平洋の神経刺激装置：2030年市場予測- 地域別分析- 製品別、用途別、エンドユーザー別

Asia Pacific Neurostimulation Devices Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 86 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.53円
アジア太平洋の神経刺激装置：2030年市場予測- 地域別分析- 製品別、用途別、エンドユーザー別
出版日: 2024年04月05日
発行: The Insight Partners
ページ情報: 英文 86 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の神経刺激装置市場は、2022年に11億9,794万米ドルと評価され、2030年には25億1,730万米ドルに達すると予測され、2022年から2030年までのCAGRは9.7%と推定されます。

神経刺激装置の進歩と承認の増加がアジア太平洋の神経刺激装置市場を牽引

メーカー各社は、植え込み型神経刺激装置などの先進的な製品や技術の開発に多額の投資を行っています。さらに、神経刺激装置市場では、新たな用途を持つ新規の神経刺激装置に対する食品医薬品局（FDA）の承認の増加が観察されています。2021年2月、Mainstay Medical社は、難治性の慢性腰痛を治療するための埋め込み型回復神経刺激システムReActiv8を開発しました。2021年3月、アボット社は、深部脳刺激患者が自宅にいながら遠隔操作で機器のプログラムやリセットを行えるように設計されたバーチャルクリニック、NeuroSphereを発表しました。2021年1月、ボストン・サイエンティフィック社は、個別化された疼痛緩和のための治療オプションを組み合わせた脊髄刺激装置（SCS）システムのポートフォリオであるWaveWriter Alphaを発表しました。

このため、神経刺激装置の進歩や承認件数の増加は、予測期間中、神経刺激装置市場に有利な機会をもたらすと予想されます。

アジア太平洋の神経刺激装置市場概要

アジア太平洋の神経刺激装置市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に細分化されます。アジア太平洋の市場は、全地域の中で最も急成長が見込まれています。インド、オーストラリア、韓国などの国々における神経疾患に関する意識の高まりが、この地域における市場の成長を決定付けています。また、アジア太平洋の神経刺激装置市場は、日本や中国などの医療機器産業の開拓が進んでいることから、成長が見込まれています。また、神経学における革新的な技術動向や、人工知能（AI）や機械学習（ML）の急速な導入は、同地域の市場を牽引するいくつかの要因となっています。さらに、神経学における政府の支援策や調査も市場の成長を後押ししています。

アジア太平洋の神経刺激装置市場の収益と2030年までの予測（金額）

アジア太平洋の神経刺激装置市場のセグメンテーション

アジア太平洋の神経刺激装置市場は、製品、用途、エンドユーザー、国によって区分されます。製品別では、アジア太平洋の神経刺激装置市場は脊髄刺激装置、脳深部刺激装置、仙骨神経刺激装置、迷走神経刺激装置、その他に区分されます。脊髄刺激装置セグメントは2022年に最大の市場シェアを占めました。

用途別では、アジア太平洋の神経刺激装置市場は疼痛管理、てんかん、尿失禁・便失禁、パーキンソン病、その他に分類されます。疼痛管理分野が2022年に最大の市場シェアを占めました。

エンドユーザー別では、アジア太平洋の神経刺激装置市場は病院、専門クリニック、その他に区分されます。病院セグメントが2022年に最大の市場シェアを占めました。

国別では、アジア太平洋の神経刺激装置市場は、英国、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に区分されます。2022年のアジア太平洋の神経刺激装置市場シェアは中国が独占。

Medtronic Plc、Boston Scientific Corp、Abbott Laboratories、Nevro Corp、LivaNova Plc、Mainstay Medicalなどがアジア太平洋の神経刺激装置市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の神経刺激装置市場- 主要産業力学

  • 市場促進要因
    • 神経疾患の有病率の増加
    • 脊髄損傷の症例の増加
  • 市場抑制要因
    • 専門家の不足
  • 市場機会
    • 神経刺激装置の進歩と承認の増加
  • 今後の動向
    • 非侵襲的治療に対する需要の高まり
  • 影響分析

第5章 神経刺激装置市場：アジア太平洋市場分析

  • アジア太平洋の神経刺激装置市場売上高、2022年～2030年

第6章 アジア太平洋の神経刺激装置市場-製品別

  • 脊髄刺激装置
  • 脳深部刺激装置
  • 仙骨神経刺激装置
  • 迷走神経刺激装置
  • その他

第7章 アジア太平洋の神経刺激装置市場：用途別

  • 疼痛管理
  • てんかん
  • 尿失禁および便失禁
  • パーキンソン病
  • その他

第8章 アジア太平洋の神経刺激装置市場：エンドユーザー別

  • 病院
  • 専門クリニック
  • その他

第9章 アジア太平洋の神経刺激装置市場：国別

  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋

第10章 神経刺激装置市場-業界情勢

  • 有機的展開
  • 無機的展開

第11章 企業プロファイル

  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories
  • Nevro Corp
  • LivaNova Plc
  • Mainstay Medical

第12章 付録

図表

List Of Tables

  • Table 1. Neurostimulation Devices Market Segmentation
  • Table 2. China Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. China Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Japan Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Japan Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Japan Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. India Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. India Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. India Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Australia Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Australia Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Australia Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. South Korea Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. South Korea Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. South Korea Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Rest of Asia Pacific Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Rest of Asia Pacific Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Rest of Asia Pacific Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Organic Developments Done by Companies
  • Table 21. Inorganic Developments Done by Companies
  • Table 22. Glossary of Terms, Neurostimulation Devices Market

List Of Figures

  • Figure 1. Neurostimulation Devices Market Segmentation, By Country
  • Figure 2. Neurostimulation Devices Market: Key Industry Dynamics
  • Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Asia Pacific Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Asia Pacific Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Asia Pacific Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Asia Pacific: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 22. Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  • Figure 23. China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
目次
Product Code: BMIRE00030036

The Asia Pacific neurostimulation devices market was valued at US$ 1,197.94 million in 2022 and is expected to reach US$ 2,517.30 million by 2030; it is estimated to register a CAGR of 9.7% from 2022 to 2030.

Growing Advances and Approvals for Neurostimulation Devices Drive Asia Pacific Neurostimulation Devices Market

Manufacturers are investing a significant amount in developing advanced products and technologies such as implantable neurostimulation devices. Additionally, an increase in Food and Drug Administration (FDA) approvals for novel neurostimulators with new applications are observed in the neurostimulation devices market. Following are a few advances and approvals for the neurostimulation devices, in February 2021, Mainstay Medical developed an implantable restorative neurostimulation system, ReActiv8, to treat intractable chronic low back pain. In March 2021, Abbott launched NeuroSphere, a virtual clinic designed to help deep brain stimulation patients program and reset their devices remotely from the comfort of their own homes. In January 2021, Boston Scientific Corporation released the WaveWriter Alpha, a portfolio of Spinal Cord Stimulator (SCS) systems that combine therapy options for personalized pain relief.

Therefore, the rising number of advances and approvals for neurostimulation devices is expected to provide lucrative opportunities for the neurostimulation devices market during the forecast period.

Asia Pacific Neurostimulation Devices Market Overview

The Asia Pacific neurostimulation devices market is subsegmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in Asia Pacific is expected to be the fastest growing among all the regions. The rising awareness regarding neurological disorders among countries such as India, Australia, and South Korea defines the market's growth in the region. The neurostimulation devices market in Asia Pacific is also expected to grow due to the rising development of the medical device industry in countries such as Japan and China. In addition, innovative technology trends in neurology and the rapid adoption of artificial intelligence (AI) and machine learning (ML) are a few factors that drive the market in the region. Furthermore, supportive government initiatives and research in neurology also boost market growth.

Asia Pacific Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Neurostimulation Devices Market Segmentation

The Asia Pacific neurostimulation devices market is segmented based on product, application, end user, and country. Based on product, the Asia Pacific neurostimulation devices market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held the largest market share in 2022.

In terms of application, the Asia Pacific neurostimulation devices market is categorized into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held the largest market share in 2022.

By end user, the Asia Pacific neurostimulation devices market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific neurostimulation devices market is segmented into the UK, China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific neurostimulation devices market share in 2022.

Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, and Mainstay Medical are among the leading companies operating in the Asia Pacific neurostimulation devices market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Neurostimulation Devices Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of Neurological Disorders
    • 4.1.2 Rising Cases of Spinal Cord Injury
  • 4.2 Market Restraints
    • 4.2.1 Lack of Expert Professionals
  • 4.3 Market Opportunities
    • 4.3.1 Growing Advances and Approvals for Neurostimulation Devices
  • 4.4 Future Trends
    • 4.4.1 Rising Demand for Noninvasive Treatment
  • 4.5 Impact Analysis

5. Neurostimulation Devices Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Spinal Cord Stimulator
    • 6.3.1 Overview
    • 6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Deep Brain Stimulator
    • 6.4.1 Overview
    • 6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Sacral Nerve Stimulator
    • 6.5.1 Overview
    • 6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Vagus Nerve Stimulator
    • 6.6.1 Overview
    • 6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Pain Management
    • 7.3.1 Overview
    • 7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Epilepsy
    • 7.4.1 Overview
    • 7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Urinary and Fecal Incontinence
    • 7.5.1 Overview
    • 7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Parkinson's Disease
    • 7.6.1 Overview
    • 7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Specialty Clinics
    • 8.4.1 Overview
    • 8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

  • 9.1 Asia Pacific: Neurostimulation Devices Market
    • 9.1.1 Overview
    • 9.1.2 Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
      • 9.1.2.1 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 9.1.2.2 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.2.1 China: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.2.2 China: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.2.3 China: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.3 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 9.1.2.4 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.4.1 Japan: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.4.2 Japan: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.4.3 Japan: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.5 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 9.1.2.6 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.6.1 India: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.6.2 India: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.6.3 India: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.7 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 9.1.2.8 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.8.1 Australia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.8.2 Australia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.8.3 Australia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.9 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 9.1.2.10 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.10.1 South Korea: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.10.2 South Korea: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.10.3 South Korea: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.11 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 9.1.2.12 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.12.1 Rest of Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.12.2 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.12.3 Rest of Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

  • 10.1 Overview
  • 10.2 Organic Developments
    • 10.2.1 Overview
  • 10.3 Inorganic Developments
    • 10.3.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Boston Scientific Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Abbott Laboratories
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Nevro Corp
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 LivaNova Plc
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Mainstay Medical
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms